• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
NTI 0.00% 7.8¢

NEUROTECH INTERNATIONAL LIMITED

Neurotech International Limited is an Australia-based clinical-stage biopharmaceutical... Neurotech International Limited is an Australia-based clinical-stage biopharmaceutical development company. The Company is focused predominately on pediatric neurological disorders with a broad-spectrum oral cannabinoid drug therapy called NTI164. It has completed a Phase II/III randomized, double-blind, placebo-controlled clinical trial in autism spectrum disorder (ASD) with clinically significant benefits reported across a number of clinically validated measures and safety. In addition, it has completed and reported significant and clinically meaningful Phase I/II trials in ASD and pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS) and pediatric acute-onset neuropsychiatric syndrome (PANS), collectively PANDAS/PANS along with Rett Syndrome. NTI164 is being developed as a therapeutic drug product for a range of neurological disorders in children where neuroinflammation is involved.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
NTI 11:40 11 2.5K
11:40 Last post  htae39 Comments Created with Sketch.  11  Views Created with Sketch.  2.5K 
NTI
Just Cheap or Just dreaming
14/07/24 7 3.9K
14/07/24 Last post  mj873 Comments Created with Sketch.  7  Views Created with Sketch.  3.9K 
NTI 11/07/24 3 1.5K
Metals & Mining SECTOR NEWS

Infini Resources continues winning streak having identified major fault system and magnetic anomalies

I88
22 Jul 2024
INFINI RESOURCES LIMITED
11/07/24 Last post  NZ Trader Comments Created with Sketch.  3  Views Created with Sketch.  1.5K 
NTI 11/07/24 6 2.5K
11/07/24 Last post  hvacgeek Comments Created with Sketch.  6  Views Created with Sketch.  2.5K 
NTI 09/07/24 3 1.1K
09/07/24 Last post  Bluebush Comments Created with Sketch.  3  Views Created with Sketch.  1.1K 
NTI 05/07/24 1 600
05/07/24 Last post  ASX News Comments Created with Sketch.  1  Views Created with Sketch.  600 
NTI 01/07/24 0 295
01/07/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  295 
NTI 28/06/24 0 401
28/06/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  401 

See All Discussions arrow Created with Sketch.

Timeline

Phase II/III autism trial shows further benefits
18 Jul 08:25
 
Investor Presentation
10 Jul 14:33
 
Significant improvement in Autism patients at 12 weeks
10 Jul 08:35
 
US FDA orphan drug designation requested for PANDAS/PANS
09 Jul 08:37
 
Appointment of Chief Medical Officer
05 Jul 08:44
 
Release of Shares from Voluntary Escrow
01 Jul 16:47
 
View More arrow Created with Sketch.
(20min delay)
Last
7.8¢
Change
0.000(0.00%)
Mkt cap ! $81.39M
Open High Low Value Volume
7.9¢ 8.1¢ 7.8¢ $42.19K 529.2K

Buyers (Bids)

No. Vol. Price($)
3 43108 7.8¢
 

Sellers (Offers)

Price($) Vol. No.
7.9¢ 36369 1
View Market Depth
Last trade - 14.33pm 22/07/2024 (20 minute delay) ?
Last
7.8¢
  Change
0.000 ( 1.27 %)
Open High Low Volume
7.8¢ 8.1¢ 7.8¢ 176700
Last updated 14.48pm 22/07/2024 ?
NTI (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.